Cabot Corporation (CBT)
NYSE: CBT · Real-Time Price · USD
72.00
-3.72 (-4.91%)
Nov 3, 2026, 4:00 PM EST - Market closed
Cabot Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| 3,744 | 3,713 | 3,994 | 3,931 | 4,321 | |
Revenue Growth | 0.83% | -7.04% | 1.60% | -9.03% | 26.75% |
Cost of Revenue | 2,863 | 2,767 | 3,022 | 3,097 | 3,443 |
Gross Profit | 881 | 946 | 972 | 834 | 878 |
Selling, General & Admin | 271 | 255 | 282 | 254 | 255 |
Research & Development | 54 | 57 | 63 | 57 | 55 |
Operating Expenses | 325 | 312 | 345 | 311 | 310 |
Operating Income | 556 | 634 | 627 | 523 | 568 |
Interest Expense | -75 | -76 | -81 | -90 | -56 |
Interest & Investment Income | 29 | 27 | 32 | 31 | 11 |
Earnings From Equity Investments | 6 | 7 | 6 | 5 | 10 |
Currency Exchange Gain (Loss) | - | -8 | -46 | -35 | -13 |
Other Non Operating Income (Expenses) | 5 | -1 | 18 | 20 | 3 |
EBT Excluding Unusual Items | 521 | 583 | 556 | 454 | 523 |
Merger & Restructuring Charges | - | -11 | -13 | -4 | -3 |
Gain (Loss) on Sale of Investments | - | - | -8 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | -3 | -207 |
Other Unusual Items | -109 | - | - | - | 18 |
Pretax Income | 412 | 572 | 535 | 456 | 345 |
Income Tax Expense | 165 | 196 | 111 | -28 | 102 |
Earnings From Continuing Operations | 247 | 376 | 424 | 484 | 243 |
Net Income to Company | 247 | 376 | 424 | 484 | 243 |
Minority Interest in Earnings | -34 | -45 | -44 | -39 | -34 |
Net Income | 213 | 331 | 380 | 445 | 209 |
Preferred Dividends & Other Adjustments | - | 5 | 6 | 8 | 3 |
Net Income to Common | 213 | 326 | 374 | 437 | 206 |
Net Income Growth | -34.66% | -12.83% | -14.42% | 112.14% | -16.60% |
Shares Outstanding (Basic) | 52 | 54 | 55 | 56 | 57 |
Shares Outstanding (Diluted) | 52 | 54 | 56 | 57 | 57 |
Shares Change | -3.69% | -2.69% | -1.42% | -0.70% | 0.18% |
EPS (Basic) | 4.10 | 6.07 | 6.79 | 7.79 | 3.65 |
EPS (Diluted) | 4.02 | 6.02 | 6.72 | 7.73 | 3.62 |
EPS Growth | -33.22% | -10.42% | -13.07% | 113.54% | -16.59% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Free Cash Flow | 214 | 364 | 451 | 351 | -111 |
Free Cash Flow Per Share | 4.10 | 6.72 | 8.10 | 6.21 | -1.95 |
Dividend Per Share | - | 1.760 | 1.660 | 1.540 | 1.480 |
Dividend Growth | - | 6.02% | 7.79% | 4.05% | 5.71% |
Gross Margin | 23.53% | 25.48% | 24.34% | 21.22% | 20.32% |
Operating Margin | 14.85% | 17.08% | 15.70% | 13.30% | 13.15% |
Profit Margin | 5.69% | 8.78% | 9.36% | 11.12% | 4.77% |
Free Cash Flow Margin | 5.72% | 9.80% | 11.29% | 8.93% | -2.57% |
EBITDA | 747 | 788 | 778 | 667 | 714 |
EBITDA Margin | 19.95% | 21.22% | 19.48% | 16.97% | 16.52% |
D&A For EBITDA | 191 | 154 | 151 | 144 | 146 |
EBIT | 556 | 634 | 627 | 523 | 568 |
EBIT Margin | 14.85% | 17.08% | 15.70% | 13.30% | 13.15% |
Effective Tax Rate | 40.05% | 34.27% | 20.75% | - | 29.57% |